The Latin America, Middle East and Africa Hemodynamic Monitoring Devices Market would witness market growth of 7.7% CAGR during the forecast period (2023-2030). In the year 2026, the LAMEA market's volume is expected to surge to 266.7 thousand Units, showcasing a growth of 9.1% (2023-2030).
New methods of hemodynamic monitoring have the potential to improve the management of cardiovascular patients during anaesthesia and postoperative care because they offer precise and repeatable measurements that can be used to identify hemodynamic changes and their causes, improve hemodynamic conditions like oxygen delivery to the tissues, and give feedback on the efficacy of therapeutic interventions. The switch to less invasive or non-invasive monitoring techniques and the shift from static to dynamic variables for assessing requirements like cardiac preload and fluid responsiveness further propel the market's expansion.
In addition, the market is expanding at a rate further accelerated by the widespread acceptance of sedentary lifestyles and the rising number of yearly surgeries. Critical congenital heart disease (CCHD) screening is becoming increasingly necessary, which presents a significant possibility for market expansion. The market's growth rate is fueled by attractive reimbursement policies and the unhealthily bad diet prevalent in large cities. The rise in R&D spending by public and commercial organizations for efficient treatments fuels the expansion of the market. The market is expected to grow due to the development of the healthcare infrastructure, particularly in emerging economies, the increasing emphasis on personalized medicine and tailored treatment methods, favorable reimbursement policies, and healthcare reforms that encourage the adoption of cutting-edge monitoring technologies.
The cases of heart attacks and heart-related diseases are on the rise in Brazil. The Agencia Brasil (the national public news agency, run by the Brazilian government) reported that the National Institute of Cardiology (INC) conducted a new study. According to this INC study, there was a noticeable increase in heart attack admissions in Brazil between 2008 and 2022. Additionally, it has been noted that many adults smoke in this region. Ultimately, this contributes to the rising heart disease in the UAE. A sedentary lifestyle is a primary factor in the increased risk of heart disease. Owing to all these factors, there will be an increased demand in the LAMEA region.
The Brazil market dominated the LAMEA Hemodynamic Monitoring Devices Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $29.2 Million by 2030. The Argentina market is estimated to grow at a CAGR of 8.3% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 7.4% during (2023 - 2030).
Based on Product, the market is segmented into Monitors and Disposables. Based on System Type, the market is segmented into Non-Invasive, Minimally Invasive and Invasive. Based on End Use, the market is segmented into Hospitals, Catheterization Labs, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Edwards Lifesciences Corporation, GE HealthCare Technologies, Inc., Baxter International, Inc., ICU Medical, Inc., Masimo Corporation, Deltex Medical Group Plc., Sramek BioDynamics, Inc., Osypka Medical GmbH, Medtronic PLC, and Koninklijke Philips N.V.
New methods of hemodynamic monitoring have the potential to improve the management of cardiovascular patients during anaesthesia and postoperative care because they offer precise and repeatable measurements that can be used to identify hemodynamic changes and their causes, improve hemodynamic conditions like oxygen delivery to the tissues, and give feedback on the efficacy of therapeutic interventions. The switch to less invasive or non-invasive monitoring techniques and the shift from static to dynamic variables for assessing requirements like cardiac preload and fluid responsiveness further propel the market's expansion.
In addition, the market is expanding at a rate further accelerated by the widespread acceptance of sedentary lifestyles and the rising number of yearly surgeries. Critical congenital heart disease (CCHD) screening is becoming increasingly necessary, which presents a significant possibility for market expansion. The market's growth rate is fueled by attractive reimbursement policies and the unhealthily bad diet prevalent in large cities. The rise in R&D spending by public and commercial organizations for efficient treatments fuels the expansion of the market. The market is expected to grow due to the development of the healthcare infrastructure, particularly in emerging economies, the increasing emphasis on personalized medicine and tailored treatment methods, favorable reimbursement policies, and healthcare reforms that encourage the adoption of cutting-edge monitoring technologies.
The cases of heart attacks and heart-related diseases are on the rise in Brazil. The Agencia Brasil (the national public news agency, run by the Brazilian government) reported that the National Institute of Cardiology (INC) conducted a new study. According to this INC study, there was a noticeable increase in heart attack admissions in Brazil between 2008 and 2022. Additionally, it has been noted that many adults smoke in this region. Ultimately, this contributes to the rising heart disease in the UAE. A sedentary lifestyle is a primary factor in the increased risk of heart disease. Owing to all these factors, there will be an increased demand in the LAMEA region.
The Brazil market dominated the LAMEA Hemodynamic Monitoring Devices Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $29.2 Million by 2030. The Argentina market is estimated to grow at a CAGR of 8.3% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 7.4% during (2023 - 2030).
Based on Product, the market is segmented into Monitors and Disposables. Based on System Type, the market is segmented into Non-Invasive, Minimally Invasive and Invasive. Based on End Use, the market is segmented into Hospitals, Catheterization Labs, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Edwards Lifesciences Corporation, GE HealthCare Technologies, Inc., Baxter International, Inc., ICU Medical, Inc., Masimo Corporation, Deltex Medical Group Plc., Sramek BioDynamics, Inc., Osypka Medical GmbH, Medtronic PLC, and Koninklijke Philips N.V.
Scope of the Study
Market Segments Covered in the Report:
By Product (Volume, Thousand Units, USD Million, 2019-2030)- Monitors
- Disposables
- Non-Invasive
- Minimally Invasive
- Invasive
- Hospitals
- Catheterization Labs
- Others
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Edwards Lifesciences Corporation
- GE HealthCare Technologies, Inc.
- Baxter International, Inc.
- ICU Medical, Inc.
- Masimo Corporation
- Deltex Medical Group Plc.
- Sramek BioDynamics, Inc.
- Osypka Medical GmbH
- Medtronic PLC
- Koninklijke Philips N.V.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 5. LAMEA Hemodynamic Monitoring Devices Market by Product
Chapter 6. LAMEA Hemodynamic Monitoring Devices Market by System Type
Chapter 7. LAMEA Hemodynamic Monitoring Devices Market by End-use
Chapter 8. LAMEA Hemodynamic Monitoring Devices Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- Edwards Lifesciences Corporation
- GE HealthCare Technologies, Inc.
- Baxter International, Inc.
- ICU Medical, Inc.
- Masimo Corporation
- Deltex Medical Group Plc.
- Sramek BioDynamics, Inc.
- Osypka Medical GmbH
- Medtronic PLC
- Koninklijke Philips N.V.
Methodology
LOADING...
